Clin2
NCT07688083Worth exploringNot yet recruiting

Testing a new Ebola blood test

Ebola Hemorrhagic Fever

Part of Infections clinical trials.

This trial is testing a new, faster way to detect Ebola in blood samples. They are using stored blood samples to see if the new test works as well as the standard one.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
Any age
Study type
Observational

Who can take part

  • You must have a stored blood sample from a previous Ebola test.
  • Your sample must be available in a biobank (a storage facility for medical samples).
  • The sample can be from a person who tested positive or negative for Ebola.
  • No other health requirements are needed.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07681752Not yet recruiting
Faster tests for ebola and lassa fever using stored blood samples

This study is testing a new, faster way to detect Ebola and Lassa fever viruses using stored blood samples. Your sample could help improve diagnosis and care for future patients.

NCT03576690AVAILABLE
Expanded access to REGN-EB3 treatment for Ebola

This trial provides an experimental antibody treatment called REGN-EB3 to people infected with Ebola virus. It aims to treat the infection and potentially improve recovery, and is available through special access in areas with Ebola outbreaks.

NCT06841614Not yet recruiting· Phase 3
Study of a new medicine to prevent Ebola after exposure

This trial tests a new medicine to prevent Ebola after you have been exposed. If you had close contact with someone who has Ebola in the last 5 days, this study could help you stay healthy.

Kinshasa
NCT06531031Not yet recruiting
Testing a new blood test for bloodstream infections

This study tests a new blood test that may quickly find bacteria or yeast causing a bloodstream infection. It uses a small extra blood sample taken at the same time as your regular blood culture, and could help doctors identify the infection faster.

Indianapolis, Indiana
NCT06624787Recruiting
Rapid test for Crimean-Congo hemorrhagic fever

This trial is developing a quick, point-of-care diagnostic test for Crimean-Congo hemorrhagic fever (CCHF), a serious viral illness. If you have symptoms and are being tested for CCHF, this study could help confirm the diagnosis faster.

Erzurum
NCT05067166AVAILABLE
Ebola treatment for infected or exposed patients

This trial provides an experimental antibody treatment called ansuvimab to people who have Ebola or have been recently exposed to it. The goal is to help their bodies fight the virus and prevent illness.

Hear when a new Ebola Hemorrhagic Fever trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.